Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
235,704,040
-
Total 13F shares
-
207,372,865
-
Share change
-
+7,266,348
-
Total reported value
-
$4,143,053,602
-
Put/Call ratio
-
10%
-
Price per share
-
$19.99
-
Number of holders
-
300
-
Value change
-
+$165,315,203
-
Number of buys
-
190
-
Number of sells
-
132
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q3 2024
As of 30 Sep 2024,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
300 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
207,372,865 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Invesco Ltd., MORGAN STANLEY, Nuveen Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., TWO SIGMA ADVISERS, LP, and AWM Investment Company, Inc..
This page lists
300
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.